HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

temsirolimus

structure in first source; inhibits mTOR protein
Also Known As:
CCI 779; CCI-779; Torisel; Wyeth brand of temsirolimus
Networked: 571 relevant articles (81 outcomes, 197 trials/studies)

Relationship Network

Drug Context: Research Results

Experts

1. Berkenblit, Anna: 12 articles (01/2014 - 01/2009)
2. Kurzrock, Razelle: 11 articles (07/2015 - 04/2011)
3. Hidalgo, Manuel: 11 articles (08/2012 - 11/2002)
4. Erlichman, Charles: 9 articles (05/2015 - 10/2006)
5. Dancey, Janet E: 9 articles (12/2012 - 10/2002)
6. Boni, Joseph P: 9 articles (06/2012 - 03/2004)
7. Escudier, Bernard: 8 articles (10/2015 - 09/2008)
8. Naing, Aung: 8 articles (07/2015 - 09/2011)
9. Dancey, Janet: 8 articles (04/2014 - 11/2004)
10. Motzer, Robert J: 8 articles (03/2014 - 12/2006)

Related Diseases

1. Renal Cell Carcinoma (Grawitz Tumor)
2. Neoplasms (Cancer)
3. Kidney Neoplasms (Kidney Cancer)
4. Squamous Cell Carcinoma (Epidermoid Carcinoma)
5. Carcinoma (Carcinomatosis)

Related Drugs and Biologics

1. Sirolimus (Rapamycin)
2. everolimus
3. bevacizumab
4. sorafenib (BAY 43-9006)
5. sunitinib (Sutent)
6. Interferon-alpha (Interferon Alfa)
7. temsirolimus
8. Interferons
9. Cisplatin (Platino)
10. Protein-Tyrosine Kinases (Tyrosine Kinase)

Related Therapies and Procedures

1. Drug Therapy (Chemotherapy)
2. Heterologous Transplantation (Xenotransplantation)
3. Castration
4. Radiotherapy
5. Aftercare (After-Treatment)